Insights

Scale expansion SubjectWell has recently augmented its platform through the acquisition of Clariness to form one of the largest global full-service patient recruitment platforms. This signals expanded global reach, broader partner ecosystems, and enhanced capacity to support multinational trials.

Science driven The company unveiled a Science-Driven Framework for protocol design, recruitment, engagement, and retention, with indices like the Patient Burden Index and Site Burden Index. This presents a talking point to position SubjectWell as a partner that improves study design efficiency and patient experience, potentially reducing time to enrollment.

Awarded credibility SubjectWell has earned multiple industry accolades in 2025, including marketing and design awards. This demonstrates market validation and brand strength, which can ease outreach to sponsors and CROs seeking reputable patient experience partners.

Visible leadership CEO engagement in industry events such as SCOPE 2026 highlights thought leadership and a focus on addressing an experience problem in clinical trials. This opens opportunities to leverage executive access for strategic discussions with sponsors prioritizing patient experience improvements.

Financial capability With revenue estimates between 25 to 50 million and total funding of 47 million, SubjectWell shows moderate scale and growth potential. This suggests capacity to support larger pilot programs, expanded services, or tiered pricing for tier-one sponsors and mid-sized trials.

Similar companies to SubjectWell

SubjectWell Tech Stack

SubjectWell uses 8 technology products and services including QuickBooks, LinkedIn Ads, Power BI, and more. Explore SubjectWell's tech stack below.

Media & News

SubjectWell's Email Address Formats

SubjectWell uses at least 4 email formats:
SubjectWell Email FormatsExamplePercentage
First.Last@subjectwell.comJohn.Doe@subjectwell.com
59%
First@subjectwell.comJohn@subjectwell.com
21%
Last@subjectwell.comDoe@subjectwell.com
16%
FLast@subjectwell.comJDoe@subjectwell.com
4%

Frequently Asked Questions

What is SubjectWell's phone number?

Minus sign iconPlus sign icon
You can contact SubjectWell's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is SubjectWell's official website and social media links?

Minus sign iconPlus sign icon
SubjectWell's official website is subjectwell.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does SubjectWell generate?

Minus sign iconPlus sign icon
As of October 2026, SubjectWell's annual revenue is estimated to be $25M - $50M.

What is SubjectWell's NAICS code?

Minus sign iconPlus sign icon
SubjectWell's NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does SubjectWell have currently?

Minus sign iconPlus sign icon
As of October 2026, SubjectWell has approximately 115 employees across 3 continents, including Africa, North America and Europe. Key team members include Head Of Operations: F. D. O., Managing Director, Europe: T. K. and Board Of Directors (observer): E. K. S. Explore SubjectWell's employee directory with LeadIQ.

What industry does SubjectWell belong to?

Minus sign iconPlus sign icon
SubjectWell operates in the Pharmaceutical Manufacturing industry.

What technology does SubjectWell use?

Minus sign iconPlus sign icon
SubjectWell's tech stack includes QuickBooks, LinkedIn Ads, Power BI, Tableau, Amazon Web Services, OneTrust, Google BigQuery and NetSuite.

What is SubjectWell's email format?

Minus sign iconPlus sign icon
SubjectWell's email format typically follows the pattern of First.Last@subjectwell.com. Find more SubjectWell email formats with LeadIQ.

How much funding has SubjectWell raised to date?

Minus sign iconPlus sign icon
As of October 2026, SubjectWell has raised $47M in funding. The last funding round occurred on Oct 18, 2022 for $35M.

When was SubjectWell founded?

Minus sign iconPlus sign icon
SubjectWell was founded in 2012.
SubjectWell logo

SubjectWell

Pharmaceutical ManufacturingTexas, United States51-200 Employees

SubjectWell is a global patient experience platform that supports clinical trial recruitment, engagement, and retention by optimizing the patient journey from protocol design through study completion. It serves sponsors, CROs, research sites, and site networks, appealing to organizations seeking predictable recruitment and improved trial experience through a combination of strategy, reach, scientific insight, services, and technology. The company positions itself within the pharmaceutical manufacturing landscape as a provider that delivers intelligence, predictability, and operational efficiency in clinical trial processes.
Based in Austin, Texas, SubjectWell has established itself as a player in the patient recruitment and trial optimization space, with recent strategic developments that include expanding its platform through acquisitions and launching a science-driven framework aimed at transforming protocol design and engagement. The organization has been active in industry events and has garnered recognition in design and marketing awards, reflecting its emphasis on patient-focused design and communication within the clinical trial ecosystem.

Section iconCompany Overview

Phone number
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
2012
Employees
51-200

Section iconFunding & Financials

  • $47M

    SubjectWell has raised a total of $47M of funding over 7 rounds. Their latest funding round was raised on Oct 18, 2022 in the amount of $35M as a Series B.

  • $25M - $50M

    SubjectWell's revenue is estimated to be in the range of $25M - $50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.